Free Trial

Roquefort Therapeutics (ROQ) Earnings Date, Estimates & Call Transcripts

Roquefort Therapeutics logo
GBX 1.36 +0.06 (+4.62%)
As of 08/29/2025 11:46 AM Eastern

Roquefort Therapeutics Earnings Summary

Roquefort Therapeutics released H2 2024 earnings on April 30, 2025, reporting an EPS of -GBX 0.75. Roquefort Therapeutics currently has a trailing EPS of -GBX 0.01

H2 2024 Earnings Resources

Latest H2
Earnings Date
Apr. 30Estimated
Get Roquefort Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Roquefort Therapeutics and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Roquefort Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2025H2 2024-GBX -0.75----


This page (LON:ROQ) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners